Q4 Results 2022: Real estate player DLF Limited and drug company Abbott India on Tuesday announced their March quarter results. Here is the main highlight of the result.
DLF Q4 Results 2022: Profit down 16% to Rs 405.33 crore
On Tuesday, realty major DLF reported a 16 per cent decline in its consolidated net profit to Rs 405.33 crore for the quarter ended March.
The company had a net profit of Rs 480.94 crore in the year-ago period, according to a regulatory filing.
Total income declined by Rs 1,652.13 crore in the fourth quarter of last fiscal, compared to Rs 1,906.59 crore in the same period last year.
Net profit increased from Rs 1,093.61 crore in FY 2020-21 to Rs 1,500.86 crore in the last financial year.
Total income increased to Rs 6,137.85 crore in 2021-22 from Rs 5,944.89 crore in the previous year.
DLF shares ended at Rs 334.15 on the BSE, up nearly 2.06 per cent.
Watch G Business Live TV streaming below:
Abbott India Q4 Results 2022: Net profit rises 39% to Rs 211 crore
Drug firm Abbott India said on Tuesday that its net profit rose 39 per cent to Rs 211 crore in the fourth quarter ended March 2022.
The company had a net profit of Rs 152 crore in the January-March quarter of the 2020-21 financial year.
It added that revenue from operations increased to Rs 1,255 crore during the period under review from Rs 1,096 crore in the year-ago period.
For the year ended March 31, 2022, the company had a net profit of Rs 799 crore. At FY21 it stands at Rs 691 crore.
Revenue from operations increased to Rs 4,919 crore in the last financial year from Rs 4,310 crore in the previous year.
The company said its board had approved a final dividend of Rs 145 and a special dividend of Rs 130 per share for the year ended March 2022.
Abbott India Shares rose nearly 7 percent to close at Rs 17,635.70 on the BSE.
With input from PTI